Generation of TNF alpha, IFN gamma, IL-6, IL-4 and IL-10 in mouse serum from trichinellosis: effect of the anti-inflammatory compound 4-deoxypyridoxine (4-DPD). 1996

S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
Laboratory of Parasitology and Parasitic Diseases, Veterinary Faculty, Aristotle University of Thessaloniki, Greece.

Infections caused by the nematode Trichinella spiralis is characterized in the host by an inflammatory response with cytokine production. In these studies we have detected TNF alpha, IL-6, IFN gamma, IL-4 and IL-10 in the serum of 10 mice infected with T. spiralis. Moreover, we detected, for the first time, these cytokines in the serum of mice treated with 4-DPD, a potent antagonist of vitamin B6 coenzyme which has anti-inflammatory properties. 4-DPD was used at 100, 400, 800 micrograms/bolus for 20 days, starting one day before the infection. After 15 days of T. spiralis infection, TNF alpha reached a maximum level, while IL-6 was maximal after 7 days, IFN gamma at 20 days and IL-4 at 14 days. IL-10 was not affected by the T. spiralis infection. When the animals were treated with 4-DPD at the reported dosages and infected with T. spiralis the inhibition of TNF alpha and IL-6, were dose-dependent in the first 7 days while IL-4 was reduced only at 400-800 micrograms/bolus. 4-DPD-treated mice did not statistically (P > 0.05) affect the generation of IFN gamma. In healthy animals the production of cytokines were not measurable, just as it was in non-infected animals treated with 4-DPD. The increase of cytokines such as, TNF alpha and IL-6 may be related to the severity of the disease, boosting the host's resistance to the pathogen and inhibiting parasite survival. In addition, the augmentation of IL-4 production enhances T and B cells and macrophage responses and may stimulate T-cell antibody-mediated response to the pathogen. 4-DPD, an inhibitor of IL-1 and inflammatory reactions, proved to be most effective on TNF alpha and IL-6, which are mainly produced by macrophages.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011736 Pyridoxine The 4-methanol form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). Pyridoxin,Pyridoxine Hydrochloride,Pyridoxol,Pyridoxol Hydrochloride,Rodex
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000871 Anthelmintics Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. Anthelmintic,Antihelmintic,Vermifuge,Vermifuges,Antihelmintics
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D014235 Trichinellosis An infection with TRICHINELLA. It is caused by eating raw or undercooked meat that is infected with larvae of nematode worms TRICHINELLA genus. All members of the TRICHINELLA genus can infect human in addition to TRICHINELLA SPIRALIS, the traditional etiological agent. It is distributed throughout much of the world and is re-emerging in some parts as a public health hazard and a food safety problem. Human Trichinellosis,Trichinelliasis,Trichinosis,Human Trichinelloses,Trichinelliases,Trichinelloses,Trichinelloses, Human,Trichinellosis, Human,Trichinoses

Related Publications

S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
September 2003, Osteoarthritis and cartilage,
S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
February 2011, Natural product research,
S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
January 2001, Transplantation proceedings,
S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
January 1996, Laboratory investigation; a journal of technical methods and pathology,
S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
August 2001, Transplantation,
S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
April 2009, The new microbiologica,
S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
July 1998, Journal of neuroimmunology,
S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
August 2008, Acta veterinaria Scandinavica,
S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
January 1999, Journal of the Egyptian Society of Parasitology,
S Frydas, and E Karagouni, and E Dotsika, and M Reale, and R C Barbacane, and I Vlemmas, and G Anogianakis, and A Trakatellis, and P Conti
March 1998, Immunogenetics,
Copied contents to your clipboard!